Ancora Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.17K | Sell |
115
-34
| -23% | -$938 | ﹤0.01% | 1548 |
|
|
2025
Q1 | $4.22K | Sell |
149
-4
| -3% | -$113 | ﹤0.01% | 1431 |
|
|
2024
Q4 | $6.36K | Buy |
153
+2
| +1% | +$83 | ﹤0.01% | 1393 |
|
|
2024
Q3 | $10.1K | Sell |
151
-88
| -37% | -$5.88K | ﹤0.01% | 1303 |
|
|
2024
Q2 | $28.4K | Buy |
239
+3
| +1% | +$356 | ﹤0.01% | 1062 |
|
|
2024
Q1 | $25.1K | Hold |
236
| – | – | ﹤0.01% | 1108 |
|
|
2023
Q4 | $23.5K | Sell |
236
-70
| -23% | -$6.96K | ﹤0.01% | 1101 |
|
|
2023
Q3 | $31.6K | Hold |
306
| – | – | ﹤0.01% | 1005 |
|
|
2023
Q2 | $37.2K | Sell |
306
-23
| -7% | -$2.8K | ﹤0.01% | 950 |
|
|
2023
Q1 | $50.5K | Buy |
329
+96
| +41% | +$14.7K | ﹤0.01% | 885 |
|
|
2022
Q4 | $42K | Hold |
233
| – | – | ﹤0.01% | 973 |
|
|
2022
Q3 | $28K | Buy |
233
+14
| +6% | +$1.68K | ﹤0.01% | 1218 |
|
|
2022
Q2 | $31K | Sell |
219
-1
| -0.5% | -$142 | ﹤0.01% | 1276 |
|
|
2022
Q1 | $38K | Hold |
220
| – | – | ﹤0.01% | 1329 |
|
|
2021
Q4 | $56K | Buy |
220
+4
| +2% | +$1.02K | ﹤0.01% | 1205 |
|
|
2021
Q3 | $83K | Sell |
216
-550
| -72% | -$211K | ﹤0.01% | 1012 |
|
|
2021
Q2 | $180K | Buy |
766
+100
| +15% | +$23.5K | ﹤0.01% | 761 |
|
|
2021
Q1 | $87K | Buy |
666
+1
| +0.2% | +$131 | ﹤0.01% | 900 |
|
|
2020
Q4 | $69K | Hold |
665
| – | – | ﹤0.01% | 801 |
|
|
2020
Q3 | $47K | Buy |
665
+115
| +21% | +$8.13K | ﹤0.01% | 845 |
|
|
2020
Q2 | $35K | Hold |
550
| – | – | ﹤0.01% | 866 |
|
|
2020
Q1 | $16K | Buy |
+550
| New | +$16K | ﹤0.01% | 1050 |
|